293 related articles for article (PubMed ID: 34051400)
21. International surveillance of Candida spp. and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2003).
Messer SA; Jones RN; Fritsche TR
J Clin Microbiol; 2006 May; 44(5):1782-7. PubMed ID: 16672407
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of Resistance Development to the Gwt1 Inhibitor Manogepix (APX001A) in
Kapoor M; Moloney M; Soltow QA; Pillar CM; Shaw KJ
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31611349
[TBL] [Abstract][Full Text] [Related]
23. CD101, a long-acting echinocandin, and comparator antifungal agents tested against a global collection of invasive fungal isolates in the SENTRY 2015 Antifungal Surveillance Program.
Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
Int J Antimicrob Agents; 2017 Sep; 50(3):352-358. PubMed ID: 28689871
[TBL] [Abstract][Full Text] [Related]
24. In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.
Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Diekema DJ
J Clin Microbiol; 2008 Jan; 46(1):150-6. PubMed ID: 18032613
[TBL] [Abstract][Full Text] [Related]
25. Manogepix, the Active Moiety of the Investigational Agent Fosmanogepix, Demonstrates
Badali H; Patterson HP; Sanders CJ; Mermella B; Gibas CFC; Ibrahim AS; Shaw KJ; Wiederhold NP
Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33722886
[TBL] [Abstract][Full Text] [Related]
26. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.
Castanheira M; Deshpande LM; Davis AP; Rhomberg PR; Pfaller MA
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784671
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity of APX001A against rare moulds using EUCAST and CLSI methodologies.
Rivero-Menendez O; Cuenca-Estrella M; Alastruey-Izquierdo A
J Antimicrob Chemother; 2019 May; 74(5):1295-1299. PubMed ID: 30753499
[TBL] [Abstract][Full Text] [Related]
28. Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing of 10 systemically active antifungal agents when tested against Candida spp.
Pfaller MA; Castanheira M; Messer SA; Rhomberg PR; Jones RN
Diagn Microbiol Infect Dis; 2014 Jun; 79(2):198-204. PubMed ID: 24736096
[TBL] [Abstract][Full Text] [Related]
29. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA
J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
[TBL] [Abstract][Full Text] [Related]
30. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
31. Rezafungin
Helleberg M; Jørgensen KM; Hare RK; Datcu R; Chowdhary A; Arendrup MC
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015032
[TBL] [Abstract][Full Text] [Related]
32. APX001A
Arendrup MC; Chowdhary A; Astvad KMT; Jørgensen KM
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104264
[TBL] [Abstract][Full Text] [Related]
33. Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods.
Montagna MT; Lovero G; Coretti C; Martinelli D; De Giglio O; Iatta R; Balbino S; Rosato A; Caggiano G
BMC Microbiol; 2015 May; 15():106. PubMed ID: 25990252
[TBL] [Abstract][Full Text] [Related]
34. Activity of contemporary antifungal agents, including the novel echinocandin anidulafungin, tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007).
Messer SA; Moet GJ; Kirby JT; Jones RN
J Clin Microbiol; 2009 Jun; 47(6):1942-6. PubMed ID: 19386851
[TBL] [Abstract][Full Text] [Related]
35. Pre-clinical development of antifungal susceptibility test methods for the testing of the novel antifungal agent E1210 versus Candida: comparison of CLSI and European Committee on Antimicrobial Susceptibility Testing methods.
Pfaller MA; Watanabe N; Castanheira M; Messer SA; Jones RN
J Antimicrob Chemother; 2011 Nov; 66(11):2581-4. PubMed ID: 21873291
[TBL] [Abstract][Full Text] [Related]
36. In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole.
Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
J Clin Microbiol; 2005 Nov; 43(11):5425-7. PubMed ID: 16272464
[TBL] [Abstract][Full Text] [Related]
37. Activity of MK-3118, a new oral glucan synthase inhibitor, tested against Candida spp. by two international methods (CLSI and EUCAST).
Pfaller MA; Messer SA; Motyl MR; Jones RN; Castanheira M
J Antimicrob Chemother; 2013 Apr; 68(4):858-63. PubMed ID: 23190764
[TBL] [Abstract][Full Text] [Related]
38. Heightened Efficacy of Anidulafungin When Used in Combination with Manogepix or 5-Flucytosine against Candida auris
John LLH; Thomson DD; Bicanic T; Hoenigl M; Brown AJP; Harrison TS; Bignell EM
Antimicrob Agents Chemother; 2023 Jun; 67(6):e0164522. PubMed ID: 37162367
[TBL] [Abstract][Full Text] [Related]
39. Echinocandin antifungal drugs in fungal infections: a comparison.
Chen SC; Slavin MA; Sorrell TC
Drugs; 2011 Jan; 71(1):11-41. PubMed ID: 21175238
[TBL] [Abstract][Full Text] [Related]
40. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
Pfaller MA; Castanheira M; Messer SA; Jones RN
Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
